Search
Showing results for "Wal yan"
Culturally secure intervention to facilitate medical follow up for Aboriginal children, after being hospitalised with chest infections, have proven to improve long-term lung health outcomes.
Learn more about all of the Clinical Trials, Platforms & Cohorts at the Wal-yan respiratory centre.
The agenda of sessions for day two
On the front cover of this month’s Medical Forum WA Magazine - Superhero viruses, #AI and the final phage.
Families affected by bronchiectasis gathered in Kings Park recently for a special event hosted by the BRIGHT Study team, celebrating community, connections, and conversations.
Dr Denby Evans, a Wal-yan Respiratory researcher, has been awarded a $25,000 Illuminate Award for her work to change that. Funding by Helping Little Hands, the award was presented at The Kids Research Institute Australia’s 2026 Illuminate PitchFest.
To investigate the feasibility of implementing recommendations of the consensus statement for the Prevention and Management of Respiratory Disease in children with severe cerebral palsy (CP) via RESPiratory hospital Admissions in children with cerebral palsy: a feasibility randomized Controlled Trial (RESP-ACT).
Promising results from an Australian-led clinical trial could drastically change the way we care for young children with cystic fibrosis (CF).
Cystic fibrosis (CF) researchers are working hard to progress phage therapy as an alternative treatment to antibiotics in people with CF who develop life-threatening lung infections.
Analysis of worldwide research shows that despite advances in neonatal care, preterm babies have lower lung function throughout their life.